Muhammad Shahzeb KHAN ; Kaneez FATIMA ; RAMEEZ
Journal of Gynecologic Oncology 2015;26(3):240-241
No abstract available. Female ; Humans ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/*therapeutic use ; Ovarian Neoplasms/mortality/*prevention & control ; Risk Factors